New England Research Associates, LLC /ID# 207237

Bridgeport, Connecticut 06606-1827

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy — Running, not enrolling